 |
answer text |
<p>The Department invests over £1 billion per year in health research through the
National Institute for Health Research (NIHR), with NIHR expenditure for all cancers
being £121.8 million in 2022/23.</p><p>Current NIHR research into breast cancer includes
a £1.3 million project to determine whether an abbreviated form of breast magnetic
resonance imaging can detect breast cancers missed by screening through mammography,
such as lobular breast cancer. The NIHR also supports research on lobular breast cancer
through its research infrastructure, including Biomedical Research Centres which are
undertaking research on early detection and genetic aspects of breast cancer. It is
difficult to attribute research infrastructure funding allocations to specific disease
and therapy areas as the staff and facilities funded through the NIHR infrastructure
supports research across disciplines.</p><p>Additionally, the NIHR supports breast
cancer research funded by research partners in the charity and public sectors through
the NIHR’s Clinical Research Network (CRN). Over the last five years the CRN has supported
delivery of 10 lobular breast cancer-related studies.</p><p>Research on the underpinning
science to understand the mechanisms of cancer, including lobular breast cancer, is
funded through the UK Research and Innovation’s (UKRI) Medical Research Council who
spend £125 million annually on cancer research. The NIHR also works closely with research
funding partners including Cancer Research UK, Breast Cancer Now, Medical Research
Council, and other cancer charities.</p>
|
|
